Neurotrophic keratitis after penetrating keratoplasty for lattice dystrophy.

Abstract

PURPOSE:

To report clinical outcomes of a patient with unilateral neurotrophic keratitis following penetrating keratoplasty for lattice dystrophy treated with topical recombinant human nerve growth factor.

OBSERVATIONS:

A 75-year-old male with lattice dystrophy and history of herpes simplex keratitis, presented with recurrent neurotrophic ulceration in the right eye two years following penetrating keratoplasty. The patient was successfully treated with topical recombinant human nerve growth factor.

CONCLUSION:

Neurotrophic keratitis is a rare chronic disorder that affects quality of life due to the risk of vision loss. Topical recombinant human nerve growth factor is a novel and effective treatment option that may help improve optical quality and patient's satisfaction as shown in this case of recurrent neurotrophic keratitis.

• Authors: Larissa Gouvea, Raphael Penatti, Karolinne Maia Rocha
• Journal: American journal of ophthalmology case reports (Am J Ophthalmol Case Rep) Vol. 22 Pg. 101058 (Jun 2021) ISSN: 2451-9936 [Electronic] United States
• PMID: 33718661 (Publication Type: Case Reports)
• Copyright: © 2021 Published by Elsevier Inc.